Posted On: May 26, 2008

ABC's 20/20 Sheds Spotlight on Tire Retailers Selling Defective Tires As New

The TV Program, 20/20 recently did a story on retailers of tires selling their inventory believed to be deteriorating, as new. While the tires may be technically unused or "new", the lengthy amount of time that the tires sit on the shelf awaiting sale leads to decay, drying out and deterioration of various tires components, including the threads, making the tires as a whole, unsafe.

The most disturbing part of the story is that over a hundred people have died as a result accidents involving tires that appeared to be new and in good condition, but in actuality, were unsafe. Consumer Experts have advised consumers to exercise extreme caution using any tires older than six years and to look at the "cryptic code" engraved in the sidewall of the tire to determine the exact year the tire was made.

On a positive note, big tire makers such as Michelin, Bridegstone/Firestone and Continental recommend that consumers not use tires older than ten years even if the tires look like they are in good shape.

In an effort to make a profit, it is believed by Consumer Experts that some of the big tire-makers are selling tires older than that recommended by consumer groups. Goodyear is believed to be one of the tire retailers selling aged tires as new to consumers according KGO-TV in San Francisco. Wal-Mart and Sears are also believed to be included as retailers selling older than recommended tires.

If you or a loved one has been injured or killed as a result of an aged tire, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at law.



Posted On: May 18, 2008

Trasylol Maker, Bayer, Recalls Blood Clotting Med From US Market

Bayer, the maker of blood clotting drug, Trasylol, announced that it plans to recall what is left of the allegedly defective medication from the US Markets - this, according to the FDA. In November of 2007, Trasylol was suspended for use in heart surgery by the FDA after a Canadian clinical study showed a heightened risk of death versus too other drugs that are used to manage blood loss during surgery.

Trasylol was previously used by patients who were at a higher risk of blood loss during coronary artery bypass surgery.

If you or a loved one has been injured or killed by Trasylol or any other defective drug, I would invite you to visit my website www.samlevine.com or contact my office, Sam Levine, Attorney at Law.


Posted On: May 11, 2008

Heart Drug, Digitek, Recalled by Icelandic Drug Maker, Actavis

A drug known as Digitek administered to patients with heart problems, has been recalled by drug manufacturer, Actavis. The crux of the drug recall is that the medication itself is said to be double the thickness and strength of the normal dosage. It is believed that the consumption of this medication may lead to complications, including arrhythmia, decreased blood pressure and death.

The generic version, Digoxin, can cause a heightened risk of toxicity in patients who have or continue to experience renal failure. The proper amount of the Digoxin, notwithstanding the defective nature of the drug, is supposed to help strengthen a weak heart and suppress fluttering and erratic heartbeats. Some patients are alleging personal injuries related to the drug, including liver failure.

FDA warnings about the defective drug go back to 1999, so Actavis has got some explaining to do, especially as Digitek patients continue to claim personal injuries from the defective drug.

If you or a loved one has been injured or killed by this or any other defective drug, I would invite you to visit my website, www.samlevine.com or contact my office, Sam Levine, Attorney at Law.